Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Phosphoprotein Phosphatases | 12 | 2019 | 346 | 3.200 |
Why?
|
DNA Repair | 23 | 2022 | 2028 | 2.950 |
Why?
|
MicroRNAs | 24 | 2021 | 3655 | 2.460 |
Why?
|
DNA Breaks, Double-Stranded | 14 | 2022 | 584 | 1.910 |
Why?
|
BRCA1 Protein | 8 | 2020 | 1039 | 1.510 |
Why?
|
DNA Damage | 21 | 2022 | 2459 | 1.480 |
Why?
|
G1 Phase | 5 | 2019 | 422 | 1.410 |
Why?
|
Genomic Instability | 6 | 2018 | 697 | 1.240 |
Why?
|
DNA | 13 | 2022 | 7172 | 1.140 |
Why?
|
Radiation Tolerance | 5 | 2018 | 509 | 1.090 |
Why?
|
Histones | 9 | 2021 | 2579 | 1.000 |
Why?
|
Ovarian Neoplasms | 12 | 2021 | 4712 | 0.920 |
Why?
|
Granzymes | 6 | 2009 | 281 | 0.850 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2019 | 112 | 0.730 |
Why?
|
Cytoplasmic Dyneins | 1 | 2018 | 26 | 0.720 |
Why?
|
RNA-Binding Proteins | 5 | 2021 | 1920 | 0.690 |
Why?
|
Down-Regulation | 6 | 2016 | 3093 | 0.610 |
Why?
|
Cell Line, Tumor | 22 | 2021 | 16959 | 0.610 |
Why?
|
Serum | 1 | 2017 | 219 | 0.590 |
Why?
|
Protein Processing, Post-Translational | 4 | 2020 | 2035 | 0.580 |
Why?
|
Phosphorylation | 15 | 2020 | 8720 | 0.570 |
Why?
|
DNA Replication | 7 | 2022 | 1443 | 0.530 |
Why?
|
Genes, BRCA1 | 1 | 2018 | 761 | 0.520 |
Why?
|
Whole-Body Irradiation | 1 | 2015 | 459 | 0.520 |
Why?
|
Replication Protein A | 2 | 2014 | 68 | 0.520 |
Why?
|
Cisplatin | 2 | 2018 | 1651 | 0.520 |
Why?
|
Organoplatinum Compounds | 1 | 2016 | 431 | 0.510 |
Why?
|
Conserved Sequence | 1 | 2017 | 1246 | 0.480 |
Why?
|
DNA Breaks | 1 | 2013 | 49 | 0.480 |
Why?
|
Cell Lineage | 2 | 2021 | 2630 | 0.480 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2020 | 2981 | 0.470 |
Why?
|
Radiation Injuries | 2 | 2018 | 1228 | 0.470 |
Why?
|
HeLa Cells | 9 | 2019 | 3258 | 0.460 |
Why?
|
Lysine | 1 | 2017 | 1026 | 0.460 |
Why?
|
RNA Interference | 9 | 2019 | 3026 | 0.450 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2020 | 5197 | 0.450 |
Why?
|
Glioblastoma | 3 | 2016 | 3344 | 0.440 |
Why?
|
Exodeoxyribonucleases | 3 | 2007 | 184 | 0.420 |
Why?
|
Cystadenocarcinoma, Serous | 3 | 2021 | 457 | 0.420 |
Why?
|
Transforming Growth Factor beta | 2 | 2016 | 1993 | 0.420 |
Why?
|
Phthalazines | 3 | 2021 | 357 | 0.410 |
Why?
|
Phosphoproteins | 5 | 2020 | 2550 | 0.410 |
Why?
|
Carrier Proteins | 3 | 2021 | 5141 | 0.380 |
Why?
|
Lymphocytes | 3 | 2014 | 2729 | 0.380 |
Why?
|
RNA, Untranslated | 1 | 2013 | 447 | 0.360 |
Why?
|
Protein Binding | 8 | 2021 | 9639 | 0.350 |
Why?
|
Cell Cycle Proteins | 7 | 2022 | 3507 | 0.350 |
Why?
|
RNA, Small Interfering | 9 | 2019 | 3645 | 0.340 |
Why?
|
Evolution, Molecular | 1 | 2017 | 1959 | 0.330 |
Why?
|
DNA Topoisomerases, Type II | 2 | 2022 | 111 | 0.330 |
Why?
|
Cell Death | 3 | 2009 | 1738 | 0.320 |
Why?
|
Nucleoside-Diphosphate Kinase | 1 | 2006 | 15 | 0.310 |
Why?
|
Apoptosis | 7 | 2020 | 10085 | 0.310 |
Why?
|
Blood Cells | 1 | 2009 | 320 | 0.310 |
Why?
|
Signal Transduction | 10 | 2020 | 23950 | 0.310 |
Why?
|
Carcinoma | 1 | 2018 | 2307 | 0.300 |
Why?
|
Cell Cycle | 6 | 2019 | 3014 | 0.300 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13714 | 0.300 |
Why?
|
Mitosis | 3 | 2019 | 1250 | 0.290 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2019 | 676 | 0.270 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2018 | 378 | 0.270 |
Why?
|
BRCA2 Protein | 4 | 2018 | 690 | 0.270 |
Why?
|
S Phase | 2 | 2022 | 434 | 0.250 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2021 | 2971 | 0.250 |
Why?
|
Poly(ADP-ribose) Polymerases | 4 | 2014 | 437 | 0.250 |
Why?
|
Serine Endopeptidases | 2 | 2006 | 1132 | 0.250 |
Why?
|
Telomere-Binding Proteins | 3 | 2020 | 96 | 0.250 |
Why?
|
Multiprotein Complexes | 3 | 2014 | 1162 | 0.250 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2008 | 1499 | 0.250 |
Why?
|
Genes, Immunoglobulin | 1 | 2004 | 284 | 0.240 |
Why?
|
Repressor Proteins | 2 | 2012 | 3075 | 0.240 |
Why?
|
Platinum | 3 | 2020 | 220 | 0.230 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2007 | 648 | 0.230 |
Why?
|
Binding Sites | 4 | 2021 | 6276 | 0.230 |
Why?
|
Hematopoietic Stem Cells | 1 | 2015 | 3447 | 0.220 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2020 | 8638 | 0.220 |
Why?
|
Animals | 30 | 2022 | 170486 | 0.220 |
Why?
|
Humans | 69 | 2022 | 708843 | 0.220 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2018 | 507 | 0.210 |
Why?
|
Feedback, Physiological | 1 | 2004 | 480 | 0.210 |
Why?
|
Antigens, Nuclear | 2 | 2016 | 206 | 0.210 |
Why?
|
Cell Line | 10 | 2020 | 16657 | 0.210 |
Why?
|
Neoplasms, Bone Tissue | 1 | 2020 | 7 | 0.210 |
Why?
|
Piperazines | 2 | 2014 | 2532 | 0.210 |
Why?
|
Mice | 19 | 2022 | 80876 | 0.200 |
Why?
|
K562 Cells | 4 | 2010 | 640 | 0.200 |
Why?
|
Telomeric Repeat Binding Protein 2 | 1 | 2019 | 18 | 0.200 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2021 | 11253 | 0.200 |
Why?
|
Pyrazines | 3 | 2021 | 1259 | 0.200 |
Why?
|
Mutation | 12 | 2021 | 29262 | 0.200 |
Why?
|
DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2020 | 67 | 0.200 |
Why?
|
Deoxycytidine | 2 | 2021 | 837 | 0.200 |
Why?
|
G-Quadruplexes | 1 | 2020 | 74 | 0.190 |
Why?
|
Lim Kinases | 1 | 2019 | 13 | 0.190 |
Why?
|
Phosphoserine | 1 | 2019 | 222 | 0.190 |
Why?
|
Pyrimidines | 3 | 2022 | 2950 | 0.190 |
Why?
|
Spodoptera | 2 | 2010 | 160 | 0.180 |
Why?
|
Brain Neoplasms | 3 | 2018 | 8776 | 0.180 |
Why?
|
Tumor Suppressor Proteins | 4 | 2014 | 2895 | 0.170 |
Why?
|
Rad52 DNA Repair and Recombination Protein | 1 | 2018 | 44 | 0.170 |
Why?
|
Gene Expression Profiling | 8 | 2021 | 9556 | 0.170 |
Why?
|
Phenylenediamines | 1 | 2018 | 91 | 0.160 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2018 | 102 | 0.160 |
Why?
|
DNA-Binding Proteins | 6 | 2016 | 9774 | 0.160 |
Why?
|
Benzoquinones | 2 | 2014 | 209 | 0.150 |
Why?
|
Chromatin | 5 | 2014 | 2693 | 0.150 |
Why?
|
Oligonucleotides, Antisense | 2 | 2016 | 434 | 0.150 |
Why?
|
RNA-Binding Protein EWS | 1 | 2018 | 206 | 0.150 |
Why?
|
Cell Division | 3 | 2012 | 4752 | 0.150 |
Why?
|
Cell Differentiation | 4 | 2010 | 11718 | 0.150 |
Why?
|
Lupus Erythematosus, Cutaneous | 2 | 2007 | 81 | 0.150 |
Why?
|
Oncogenes | 2 | 2021 | 1244 | 0.140 |
Why?
|
Glioma | 2 | 2022 | 3292 | 0.140 |
Why?
|
G2 Phase | 2 | 2014 | 148 | 0.140 |
Why?
|
Protein Phosphatase 2 | 2 | 2008 | 224 | 0.140 |
Why?
|
Lactams, Macrocyclic | 2 | 2014 | 321 | 0.140 |
Why?
|
Molecular Sequence Data | 4 | 2014 | 18748 | 0.140 |
Why?
|
Receptors, Antigen | 2 | 2005 | 53 | 0.140 |
Why?
|
Protein Transport | 2 | 2014 | 2059 | 0.140 |
Why?
|
Protein Subunits | 2 | 2010 | 1021 | 0.140 |
Why?
|
RNA, Messenger | 7 | 2014 | 13314 | 0.140 |
Why?
|
HEK293 Cells | 3 | 2019 | 4310 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2012 | 1004 | 0.130 |
Why?
|
Base Sequence | 3 | 2016 | 13352 | 0.130 |
Why?
|
Gene Expression Regulation | 6 | 2017 | 12447 | 0.130 |
Why?
|
Telomere | 1 | 2019 | 823 | 0.130 |
Why?
|
Methylation | 1 | 2017 | 1111 | 0.130 |
Why?
|
Comet Assay | 2 | 2012 | 81 | 0.130 |
Why?
|
Rad51 Recombinase | 2 | 2013 | 190 | 0.120 |
Why?
|
DNA Modification Methylases | 1 | 2014 | 209 | 0.120 |
Why?
|
3' Untranslated Regions | 3 | 2011 | 526 | 0.120 |
Why?
|
Salvage Therapy | 1 | 2020 | 1296 | 0.120 |
Why?
|
Perforin | 3 | 2008 | 171 | 0.120 |
Why?
|
Histone Deacetylases | 1 | 2018 | 758 | 0.120 |
Why?
|
Nuclear Proteins | 5 | 2020 | 5982 | 0.120 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2018 | 803 | 0.120 |
Why?
|
Substrate Specificity | 2 | 2008 | 1897 | 0.120 |
Why?
|
Immunity, Innate | 1 | 2005 | 2937 | 0.120 |
Why?
|
Alleles | 1 | 2004 | 7090 | 0.110 |
Why?
|
Micronuclei, Chromosome-Defective | 1 | 2012 | 30 | 0.110 |
Why?
|
DNA Repair Enzymes | 1 | 2014 | 360 | 0.110 |
Why?
|
Uterine Neoplasms | 1 | 2021 | 1473 | 0.110 |
Why?
|
Gene Silencing | 3 | 2008 | 1626 | 0.110 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1814 | 0.110 |
Why?
|
Loss of Heterozygosity | 1 | 2014 | 681 | 0.110 |
Why?
|
Chromosome Breakage | 1 | 2012 | 172 | 0.110 |
Why?
|
Cell Physiological Phenomena | 1 | 2013 | 160 | 0.110 |
Why?
|
Radiation, Ionizing | 1 | 2012 | 273 | 0.110 |
Why?
|
Gene Library | 1 | 2014 | 1094 | 0.100 |
Why?
|
Sequence Alignment | 1 | 2016 | 2281 | 0.100 |
Why?
|
Female | 18 | 2021 | 375205 | 0.100 |
Why?
|
DNA-Activated Protein Kinase | 2 | 2012 | 116 | 0.100 |
Why?
|
Immunoprecipitation | 2 | 2010 | 941 | 0.100 |
Why?
|
Macaca mulatta | 1 | 2017 | 2427 | 0.100 |
Why?
|
Recombination, Genetic | 3 | 2012 | 1708 | 0.100 |
Why?
|
E2F2 Transcription Factor | 1 | 2009 | 41 | 0.100 |
Why?
|
Pyrazoles | 1 | 2020 | 1954 | 0.100 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1060 | 0.100 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2009 | 94 | 0.090 |
Why?
|
Isoxazoles | 2 | 2021 | 215 | 0.090 |
Why?
|
Genes, cdc | 1 | 2009 | 126 | 0.090 |
Why?
|
Enzyme Inhibitors | 4 | 2014 | 3936 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 2 | 2014 | 2673 | 0.090 |
Why?
|
NF-kappa B | 1 | 2018 | 2563 | 0.090 |
Why?
|
Hematopoietic System | 1 | 2009 | 115 | 0.090 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2009 | 188 | 0.090 |
Why?
|
Amino Acid Sequence | 2 | 2014 | 14215 | 0.090 |
Why?
|
Mice, Inbred C57BL | 3 | 2017 | 22989 | 0.090 |
Why?
|
Aneuploidy | 1 | 2012 | 464 | 0.090 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2013 | 707 | 0.090 |
Why?
|
Radiotherapy | 1 | 2016 | 1623 | 0.090 |
Why?
|
Transcription Factors | 3 | 2020 | 12005 | 0.090 |
Why?
|
Cell Proliferation | 6 | 2020 | 10803 | 0.090 |
Why?
|
ras Proteins | 1 | 2014 | 1116 | 0.080 |
Why?
|
Bleomycin | 1 | 2009 | 503 | 0.080 |
Why?
|
Baculoviridae | 1 | 2008 | 125 | 0.080 |
Why?
|
Endopeptidases | 1 | 2012 | 827 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 2 | 2021 | 5405 | 0.080 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2007 | 58 | 0.080 |
Why?
|
Gamma Rays | 1 | 2009 | 333 | 0.080 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2007 | 93 | 0.080 |
Why?
|
Antigens, Neoplasm | 2 | 2016 | 2003 | 0.080 |
Why?
|
Subcellular Fractions | 1 | 2008 | 576 | 0.080 |
Why?
|
Catalytic Domain | 1 | 2010 | 720 | 0.080 |
Why?
|
Fibroblasts | 4 | 2019 | 4299 | 0.080 |
Why?
|
Computational Biology | 1 | 2020 | 3568 | 0.080 |
Why?
|
NM23 Nucleoside Diphosphate Kinases | 1 | 2006 | 21 | 0.080 |
Why?
|
Chromosomes, Human | 1 | 2009 | 475 | 0.080 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2016 | 4865 | 0.080 |
Why?
|
Sex Characteristics | 1 | 2017 | 2510 | 0.080 |
Why?
|
Antigens, Surface | 1 | 2011 | 1858 | 0.070 |
Why?
|
HCT116 Cells | 2 | 2020 | 412 | 0.070 |
Why?
|
Protein Structure, Tertiary | 5 | 2014 | 3972 | 0.070 |
Why?
|
Models, Biological | 3 | 2012 | 9907 | 0.070 |
Why?
|
Up-Regulation | 2 | 2021 | 4353 | 0.070 |
Why?
|
African Americans | 1 | 2021 | 5118 | 0.070 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2009 | 778 | 0.070 |
Why?
|
Neoplasms | 4 | 2022 | 20172 | 0.070 |
Why?
|
Genes, myc | 2 | 2020 | 408 | 0.070 |
Why?
|
Helminths | 1 | 2005 | 26 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2020 | 4254 | 0.070 |
Why?
|
Herpes Genitalis | 1 | 2005 | 131 | 0.070 |
Why?
|
Lung Neoplasms | 3 | 2016 | 12183 | 0.070 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2021 | 470 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2016 | 7026 | 0.070 |
Why?
|
Herpesvirus 2, Human | 1 | 2005 | 176 | 0.070 |
Why?
|
Doxorubicin | 1 | 2011 | 2235 | 0.070 |
Why?
|
Interferons | 3 | 2020 | 667 | 0.060 |
Why?
|
Prostatic Neoplasms | 2 | 2020 | 10525 | 0.060 |
Why?
|
Homeodomain Proteins | 1 | 2013 | 2459 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 3026 | 0.060 |
Why?
|
Mutation, Missense | 3 | 2009 | 2503 | 0.060 |
Why?
|
Interleukin-7 | 1 | 2004 | 149 | 0.060 |
Why?
|
RNA Editing | 1 | 2005 | 161 | 0.060 |
Why?
|
Models, Genetic | 1 | 2014 | 3539 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10507 | 0.060 |
Why?
|
Radiation-Sensitizing Agents | 2 | 2018 | 380 | 0.060 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2005 | 816 | 0.060 |
Why?
|
Recombinant Proteins | 3 | 2008 | 6850 | 0.060 |
Why?
|
Cytidine Deaminase | 1 | 2005 | 234 | 0.060 |
Why?
|
Immunoglobulin Variable Region | 1 | 2004 | 418 | 0.060 |
Why?
|
Adenosine Deaminase | 1 | 2005 | 245 | 0.060 |
Why?
|
Morpholines | 2 | 2018 | 572 | 0.060 |
Why?
|
Telomerase | 2 | 2019 | 741 | 0.060 |
Why?
|
Uridine | 1 | 2022 | 147 | 0.060 |
Why?
|
Multienzyme Complexes | 1 | 2006 | 769 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14836 | 0.060 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2012 | 1481 | 0.050 |
Why?
|
Kinetics | 1 | 2010 | 6796 | 0.050 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2009 | 1086 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 8877 | 0.050 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 96 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15252 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4677 | 0.050 |
Why?
|
Tumor Cells, Cultured | 3 | 2016 | 6571 | 0.050 |
Why?
|
Genome | 2 | 2019 | 1747 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2008 | 2836 | 0.050 |
Why?
|
Mammals | 1 | 2005 | 906 | 0.050 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2020 | 1667 | 0.050 |
Why?
|
Breast Neoplasms | 3 | 2014 | 19800 | 0.050 |
Why?
|
Amino Acid Substitution | 2 | 2018 | 1823 | 0.050 |
Why?
|
Gene Rearrangement | 1 | 2005 | 1202 | 0.050 |
Why?
|
Rats | 3 | 2019 | 25094 | 0.050 |
Why?
|
Cell Survival | 1 | 2010 | 6156 | 0.050 |
Why?
|
Virus Diseases | 1 | 2005 | 674 | 0.050 |
Why?
|
Guanine | 1 | 2020 | 283 | 0.040 |
Why?
|
Camptothecin | 2 | 2014 | 555 | 0.040 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2019 | 289 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2017 | 19423 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2014 | 1853 | 0.040 |
Why?
|
Indazoles | 1 | 2020 | 292 | 0.040 |
Why?
|
Neoplasm Staging | 3 | 2021 | 11126 | 0.040 |
Why?
|
Databases, Genetic | 2 | 2020 | 1807 | 0.040 |
Why?
|
Pyrophosphatases | 1 | 2018 | 146 | 0.040 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2019 | 919 | 0.040 |
Why?
|
Aged | 6 | 2021 | 161488 | 0.040 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2019 | 416 | 0.040 |
Why?
|
Primates | 1 | 2019 | 503 | 0.040 |
Why?
|
Acetylation | 1 | 2020 | 1123 | 0.040 |
Why?
|
Pore Forming Cytotoxic Proteins | 2 | 2007 | 134 | 0.040 |
Why?
|
Reference Standards | 1 | 2020 | 992 | 0.040 |
Why?
|
Middle Aged | 6 | 2021 | 213752 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4317 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2018 | 20170 | 0.040 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2005 | 1989 | 0.040 |
Why?
|
Escherichia coli | 1 | 2008 | 4316 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2005 | 2913 | 0.030 |
Why?
|
Ovary | 1 | 2020 | 997 | 0.030 |
Why?
|
Gene Amplification | 1 | 2020 | 1087 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2012 | 4930 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2018 | 1777 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2016 | 552 | 0.030 |
Why?
|
Cyclin B1 | 1 | 2014 | 53 | 0.030 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2014 | 118 | 0.030 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2014 | 65 | 0.030 |
Why?
|
Male | 6 | 2020 | 349524 | 0.030 |
Why?
|
Protein Engineering | 1 | 2018 | 551 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2325 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2014 | 190 | 0.030 |
Why?
|
DNA Helicases | 1 | 2019 | 825 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2007 | 3464 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2005 | 2930 | 0.030 |
Why?
|
Protein Kinase C-alpha | 1 | 2014 | 120 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 936 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 58184 | 0.030 |
Why?
|
Blotting, Western | 2 | 2014 | 5456 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 2018 | 2008 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 13202 | 0.030 |
Why?
|
Hydroxyurea | 1 | 2014 | 290 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2005 | 2277 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2020 | 6068 | 0.030 |
Why?
|
Gene Regulatory Networks | 2 | 2014 | 1712 | 0.030 |
Why?
|
DNA, Single-Stranded | 1 | 2014 | 347 | 0.030 |
Why?
|
Chromones | 1 | 2012 | 166 | 0.030 |
Why?
|
Gene Expression | 2 | 2020 | 8014 | 0.030 |
Why?
|
Exosomes | 1 | 2016 | 400 | 0.030 |
Why?
|
Piperidines | 1 | 2020 | 1582 | 0.030 |
Why?
|
Heterochromatin | 1 | 2014 | 310 | 0.030 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2011 | 52 | 0.030 |
Why?
|
DNA Fragmentation | 1 | 2012 | 248 | 0.030 |
Why?
|
Preoperative Period | 1 | 2014 | 552 | 0.030 |
Why?
|
Genetic Markers | 1 | 2018 | 2690 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2012 | 413 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2004 | 9927 | 0.030 |
Why?
|
Mice, Nude | 1 | 2018 | 3859 | 0.030 |
Why?
|
Luminescent Proteins | 1 | 2014 | 885 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2020 | 2461 | 0.030 |
Why?
|
Carboplatin | 1 | 2014 | 797 | 0.030 |
Why?
|
Retinal Pigment Epithelium | 1 | 2014 | 293 | 0.030 |
Why?
|
Chromosome Segregation | 1 | 2012 | 229 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 737 | 0.030 |
Why?
|
Macrophages | 2 | 2020 | 5784 | 0.020 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2013 | 521 | 0.020 |
Why?
|
Radiometry | 1 | 2016 | 823 | 0.020 |
Why?
|
Multigene Family | 1 | 2013 | 1125 | 0.020 |
Why?
|
Immunoblotting | 1 | 2013 | 1795 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2021 | 1711 | 0.020 |
Why?
|
Nuclear Receptor Co-Repressor 1 | 1 | 2009 | 29 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2019 | 6530 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6451 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2018 | 1597 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 384 | 0.020 |
Why?
|
Fibrosis | 1 | 2016 | 1947 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2159 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 5112 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2009 | 378 | 0.020 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2012 | 438 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2020 | 3156 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2014 | 882 | 0.020 |
Why?
|
Staurosporine | 1 | 2009 | 251 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39038 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 2987 | 0.020 |
Why?
|
Models, Molecular | 1 | 2018 | 5525 | 0.020 |
Why?
|
Models, Chemical | 1 | 2009 | 644 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2011 | 680 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3773 | 0.020 |
Why?
|
Quinazolines | 1 | 2014 | 1420 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2878 | 0.020 |
Why?
|
Tandem Repeat Sequences | 1 | 2007 | 190 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 1268 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4493 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 39292 | 0.020 |
Why?
|
Computer Simulation | 1 | 2020 | 6048 | 0.020 |
Why?
|
Caspases | 1 | 2009 | 940 | 0.020 |
Why?
|
Administration, Intravaginal | 1 | 2005 | 142 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4941 | 0.020 |
Why?
|
Transfection | 1 | 2014 | 6161 | 0.020 |
Why?
|
Megakaryocytes | 1 | 2009 | 531 | 0.020 |
Why?
|
Frameshift Mutation | 1 | 2007 | 397 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2014 | 3714 | 0.020 |
Why?
|
Proteomics | 1 | 2018 | 3244 | 0.020 |
Why?
|
Dimerization | 1 | 2007 | 909 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2018 | 3690 | 0.020 |
Why?
|
Membrane Glycoproteins | 2 | 2007 | 3812 | 0.020 |
Why?
|
Receptors, HIV | 1 | 2005 | 141 | 0.020 |
Why?
|
Genes, Essential | 1 | 2005 | 182 | 0.020 |
Why?
|
Endosomes | 1 | 2007 | 531 | 0.020 |
Why?
|
Prognosis | 2 | 2016 | 28919 | 0.020 |
Why?
|
Genes, Viral | 1 | 2005 | 774 | 0.020 |
Why?
|
Databases, Factual | 1 | 2019 | 7763 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 2011 | 2164 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2021 | 21194 | 0.020 |
Why?
|
Disease Progression | 1 | 2020 | 13298 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3693 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2014 | 6127 | 0.010 |
Why?
|
COS Cells | 1 | 2005 | 1209 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 2561 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2009 | 1849 | 0.010 |
Why?
|
Proteins | 1 | 2018 | 6151 | 0.010 |
Why?
|
Liposomes | 1 | 2005 | 754 | 0.010 |
Why?
|
Arginine | 1 | 2006 | 944 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16306 | 0.010 |
Why?
|
Melanoma, Experimental | 1 | 2005 | 560 | 0.010 |
Why?
|
Cervix Uteri | 1 | 2005 | 575 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 2006 | 830 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2007 | 2193 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 3006 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5489 | 0.010 |
Why?
|
Vagina | 1 | 2005 | 777 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 61932 | 0.010 |
Why?
|
Heterozygote | 1 | 2007 | 2780 | 0.010 |
Why?
|
Gene Frequency | 1 | 2007 | 3701 | 0.010 |
Why?
|
Erythrocytes | 1 | 2009 | 2418 | 0.010 |
Why?
|
Adult | 3 | 2020 | 211041 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 13647 | 0.010 |
Why?
|
Pedigree | 1 | 2007 | 4724 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2006 | 1897 | 0.010 |
Why?
|
Viral Proteins | 1 | 2005 | 1967 | 0.010 |
Why?
|
Virus Replication | 1 | 2005 | 2524 | 0.010 |
Why?
|
Lung | 1 | 2016 | 9706 | 0.010 |
Why?
|
Antibodies | 1 | 2005 | 2431 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2006 | 3021 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2005 | 3878 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2005 | 6684 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2007 | 17218 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11790 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 55940 | 0.010 |
Why?
|
Genotype | 1 | 2007 | 12863 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 84718 | 0.010 |
Why?
|
Child | 1 | 2018 | 73636 | 0.010 |
Why?
|
HIV-1 | 1 | 2005 | 6757 | 0.010 |
Why?
|
Inflammation | 1 | 2005 | 10019 | 0.000 |
Why?
|
Time Factors | 1 | 2005 | 41038 | 0.000 |
Why?
|
Risk Factors | 1 | 2007 | 69553 | 0.000 |
Why?
|